BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BGRO
3551
BlackRock Large Cap Growth ETF
BGRO
$9.17M
| $5.39M | ﹤0.01% |
+170,000
| New | +$5.36M |
|
3552
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.4B
| $5.39M | ﹤0.01% |
244,470
-48,402
| -17% | -$1.06M |
|
3553
Oaktree Specialty Lending
OCSL
$1.05B
| $5.39M | ﹤0.01% |
286,286
+9,559
| +3% | +$185K |
|
3554
Greenwich LifeSciences
GLSI
$199M
| $5.33M | ﹤0.01% |
308,909
+252,450
| +447% | +$3.69M |
|
|
ELQD
3555
DELISTED
iShares ESG Advanced Investment Grade Corporate Bond ETF
ELQD
| $5.32M | ﹤0.01% |
66,000
-10,000
| -13% | -$803K |
|
3556
Acumen Pharmaceuticals
ABOS
$157M
| $5.22M | ﹤0.01% |
2,158,661
+1,968,964
| +1,038% | +$6.27M |
|
3557
CervoMed
CRVO
$24.1M
| $5.2M | ﹤0.01% |
303,935
+282,119
| +1,293% | +$6.17M |
|
3558
BlackRock US Industry Rotation ETF
INRO
$34.9M
| $5.2M | ﹤0.01% |
200,000
| – | – |
|
3559
Eve Holding
EVEX
$836M
| $5.13M | ﹤0.01% |
1,265,458
-24,604
| -2% | -$124K |
|
|
BELT
3560
BlackRock ETF Trust iShares U.S. Select Equity Active ETF
BELT
$9.84M
| $5.12M | ﹤0.01% |
+170,000
| New | +$5.14M |
|
3561
Taylor Devices
TAYD
$169M
| $5.11M | ﹤0.01% |
113,615
+100,599
| +773% | +$4.88M |
|
3562
Candel Therapeutics
CADL
$738M
| $5.1M | ﹤0.01% |
823,071
+775,491
| +1,630% | +$5.82M |
|
3563
eHealth
EHTH
$43.8M
| $5.08M | ﹤0.01% |
1,122,364
-1,475,753
| -57% | -$7.43M |
|
3564
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$194M
| $5.07M | ﹤0.01% |
112,324
| – | – |
|
3565
Amylyx Pharmaceuticals
AMLX
$2.24B
| $5.07M | ﹤0.01% |
2,669,741
-1,804,981
| -40% | -$3.5M |
|
3566
Neuropace
NPCE
$460M
| $5.07M | ﹤0.01% |
670,875
+596,721
| +805% | +$6.02M |
|
3567
Global Ship Lease
GSL
$1.59B
| $5.06M | ﹤0.01% |
175,678
+57,177
| +48% | +$1.45M |
|
3568
New Mountain Finance
NMFC
$683M
| $5.02M | ﹤0.01% |
410,394
+5,149
| +1% | +$64.5K |
|
|
THRO
3569
iShares U.S. Thematic Rotation Active ETF
THRO
$6.55B
| $4.97M | ﹤0.01% |
160,000
| – | – |
|
3570
Waldencast
WALD
$218M
| $4.97M | ﹤0.01% |
1,383,655
-170,074
| -11% | -$832K |
|
3571
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $4.96M | ﹤0.01% |
218,285
-239,608
| -52% | -$5.42M |
|
3572
iShares GNMA Bond ETF
GNMA
$421M
| $4.95M | ﹤0.01% |
114,841
+15,296
| +15% | +$655K |
|
3573
Freedom Holding
FRHC
$9.73B
| $4.93M | ﹤0.01% |
65,370
-4,910
| -7% | -$356K |
|
3574
iShares Future Metaverse Tech and Communications ETF
IVRS
$7.99M
| $4.92M | ﹤0.01% |
150,000
| – | – |
|
3575
Invivyd
IVVD
$163M
| $4.92M | ﹤0.01% |
4,473,808
+3,597,239
| +410% | +$7.95M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.